TCT-76 Mid-Term Outcomes after Transcatheter Aortic Valve Replacement With a Mechanically-Expanded Versus Self-Expandable Valve: 3-Year Results From the REPRISE III Randomized Trial
| Autor: | David G. Rizik, Jeffrey Southard, Steven J. Yakubov, Michael J. Reardon, Tanvir Bajwa, Paul S. Teirstein, Leo Ihlberg, Donald E. Cutlip, Vivek Rajagopal, Dominic Allocco |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Transcatheter aortic business.industry Self expandable medicine.medical_treatment fungi food and beverages medicine.disease Surgical risk Surgery law.invention Stenosis Reprise Valve replacement Randomized controlled trial law Medicine Cardiology and Cardiovascular Medicine business |
| Zdroj: | Journal of the American College of Cardiology. 74:B76 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2019.08.114 |
| Popis: | REPRISE III is the first large randomized comparison of 2 TAVR platforms: the mechanically-expanded Lotus valve (Boston Scientific, Marlborough, Massachusetts) and self-expanding CoreValve (CV) (Medtronic, Dublin, Ireland). In aortic stenosis patients with high/extreme surgical risk, Lotus was |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|